C. H. Brahe Et Al. , "DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION," Annual European Congress of Rheumatology (EULAR) , Madrid, Spain, pp.1401-1402, 2019
Brahe, C. H. Et Al. 2019. DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION. Annual European Congress of Rheumatology (EULAR) , (Madrid, Spain), 1401-1402.
Brahe, C. H., Ornbjerg, L., Jacobsson, L. T. H., Nissen, M., Kristianslund, E., Mann, H., ... Santos, M. J.(2019). DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION . Annual European Congress of Rheumatology (EULAR) (pp.1401-1402). Madrid, Spain
Brahe, Cecilie Et Al. "DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION," Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 2019
Brahe, Cecilie H. Et Al. "DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION." Annual European Congress of Rheumatology (EULAR) , Madrid, Spain, pp.1401-1402, 2019
Brahe, C. H. Et Al. (2019) . "DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION." Annual European Congress of Rheumatology (EULAR) , Madrid, Spain, pp.1401-1402.
@conferencepaper{conferencepaper, author={Cecilie Heegaard Brahe Et Al. }, title={DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION}, congress name={Annual European Congress of Rheumatology (EULAR)}, city={Madrid}, country={Spain}, year={2019}, pages={1401-1402} }